MedPath
NMPA Approval

DaShanZha Granules

国药准字Z42021544

September 21, 2020

国药准字Z42021544

Drug Information

大山楂颗粒

波儿康

颗粒剂

每袋装15g,150g

中药

September 21, 2020

Company Information

Applicant Company

湖北省京山县石龙镇太子山

Manufacturing Company

湖北省沙洋县沙洋经济开发区洪福路5号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

大山楂颗粒 - NMPA 批准文号 | MedPath